Previously untreated chronic lymphocytic leukemia (CLL) patients experienced increased progression-free and overall survival when treated with ibrutinib-rituximab compared to current standard chemoimmunotherapy. Rates of high grade adverse events were sim
by 2minmed 5 years ago | via Instagram


I looooove the new vegan box from @thehealthybox - the vanilla sparkling water is ???????????????????????? #thehealthybox #healthybox #ramlösa #yummie #friggs #vegan #instagood #umeå #nordmaling
by annawii 7 years ago | via Instagram